Table 2 Levels of IgG antibodies against P. vivax blood stage proteins according to the studied genotypes

INFG

+874T > A

AA

1.36 (0.63–2.78)

1.58 (0.78–7.29)

2.92 (1.00–7.63)

AT

1.14 (0.51–2.18)

1.41 (0.77–4.73)

2.05 (0.49–6.64)

TT

2.50 (1.18–3.00)

5.17 (0.86–18.5)

4.66 (1.50–8.11)

TNFA

−1031T > C

TT

1.41 (0.60–2.97)

1.34 (0.79–5.38)

3.74 (0.96–7.57)

TC

1.49 (0.58–2.50)

1.66 (0.79–6.87)

2.60 (0.51–6.93)

CC

1.45 (1.01–1.52)

8.57 (0.73–14.89)

2.12 (1.32–2.59)

TNFA

−308G > A

GG

1.67 (0.65–2.80)

1.66 (0.79–6.30)

2.92 (0.89–7.58)

GA

1.14 (0.58–2.23)

1.48 (0.73–3.42)

2.61 (1.18–6.54)

AA

0.62 (0.51–0.62)

1.39 (0.96–1.39)

1.30 (0.28–1.30)

TNFA

−238G > A

GG

1.45 (0.64–2.66)

1.59 (0.81–5.59)

2.61 (0.94–7.47)

GA

1.34 (0.53–2.91)

1.48 (0.76–7.16)

5.15 (1.69–8.16)

AA

2.32 (2.32–2.32)

1.28 (1.28–1.28)

3.04 (3.04–3.04)

IL10

−819C > T

CC

1.35 (0.63-2.53)

2.01 (0.79–5.91)

3.50 (0.55–7.48)

CT

1.45 (0.60-2.77)

1.29 (0.77–5.06)

2.61 (0.87–7.60)

TT

2.22 (0.83–2.84)

2.18 (1.35–6.31)

1.98 (1.22–7.13)

IL10

−592C > A

CC

1.41 (0.62–2.50)

1.59 (0.76–5.91)

4.92 (1.10–7.63)

CA

1.52 (0.62–2.78)

1.46 (0.81–5.46)

2.59 (0.94–7.26)

AA

1.22 (0.52–2.85)

1.84 (1.21–4.32)

2.50 (1.07–5.97)